Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipiodol as Imaging Biomarker in Liver Cancer TACE
NCT01877187Phase 2Completed
- Sponsor
- Yale University
- Start
- Apr 2013
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ethiodized oil in hepatocellular carcinoma (HCC), liver metastases, sponsored by Yale University. Started Apr 2013; status: completed.
02
Drugs
ethiodized oil
03
Conditions
hepatocellular carcinoma (HCC)liver metastases
Beyond the preview
Go deeper on NCT01877187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01877187.